Internal Medicine Cases
Case number 27 A 38-year-old man -newly diagnosed as high grade B cell lymphoma - who received bendamustin as the chemotherapy agent 4 days ago came to the emergency ward with the complaint of severe diarrhea (10 times a day) and significant urine output…
Case follow up
After 6 sessions of hemodialysis and supportive care, the patient started to urinate about 3-4 liters per day (which was consistent with polyuric phase of ATN). Exessive hydration was prescribed.
Three days after antibiotics administration, he became afebrile and WBC count started to rise.
At the time of discharge he was well oriented and alert.
Urine output was about 2 liters per day. His final lab tests:
Cr 1.1
Urea 67
K 3.8
P 4.4
Ca 9.4
Uric acid 5.4
WBC 5.6
Hb 9.9
Plt 215000
He was then discharged and referred to the hematology clinic.
End of case 27
After 6 sessions of hemodialysis and supportive care, the patient started to urinate about 3-4 liters per day (which was consistent with polyuric phase of ATN). Exessive hydration was prescribed.
Three days after antibiotics administration, he became afebrile and WBC count started to rise.
At the time of discharge he was well oriented and alert.
Urine output was about 2 liters per day. His final lab tests:
Cr 1.1
Urea 67
K 3.8
P 4.4
Ca 9.4
Uric acid 5.4
WBC 5.6
Hb 9.9
Plt 215000
He was then discharged and referred to the hematology clinic.
End of case 27
💯4👍1🙏1
Case number 28
A 33 y/o confused man was brought to the emergency ward by EMS. He does not answer your questions and just moans and complaints about headache.
Initial vital signs:
BP 130/80
PR 100
RR 24
T 37.8
Weight 80 kg
BS 100
Pupils were midsize and reactive to light
No focal neurological deficit was detected at the beginning.
Fundoscopy showed no significant pathology.
While searching the patient's pockets for any evidence and identity cards, you find a badge with the label "hemophilia A".
A 33 y/o confused man was brought to the emergency ward by EMS. He does not answer your questions and just moans and complaints about headache.
Initial vital signs:
BP 130/80
PR 100
RR 24
T 37.8
Weight 80 kg
BS 100
Pupils were midsize and reactive to light
No focal neurological deficit was detected at the beginning.
Fundoscopy showed no significant pathology.
While searching the patient's pockets for any evidence and identity cards, you find a badge with the label "hemophilia A".
👍8❤3
What is your next step for the patient?
Anonymous Quiz
19%
4000 units recombinant factor VIII immediate infusion
45%
Emergent brain CT scan w/o contrast
3%
Brain MRI with gadolinium
9%
2 units fresh frozen plasma immediate infusion
1%
Intravenous Thiamine infusion
1%
1 unit packed RBC immediate infusion
21%
Checking CBC diff, PT, INR, PTT, Urine toxicology
What would be the coagulative panel of the patient?
Anonymous Quiz
16%
Plt 50000 , INR 1.2 , PTT 30
42%
Plt 250000 , INR 1.2, PTT 80
8%
Plt 50000 , INR 1.9, PTT 70
10%
Plt 250000, INR 1.9, PTT 30
18%
Plt 250000, INR 1.9, PTT 80
5%
Plt 250000, INR 1.2, PTT 30
Internal Medicine Cases
What is your next step for the patient?
In hemophilia A patients with suspected severe or life-threatening bleeding it is important to "Treat first, evaluate second, plan further therapy third"
For potentially serious or life-threatening bleeding, give factor before imaging or other evaluations.
Initial examination findings may be subtle or absent; treat based on the medical history.
If a diagnostic procedure is required (lumbar puncture, arterial blood gas, arthrocentesis), give factor to raise the level to 100% before performing the procedure.
If the patient requires transfer to another facility, give factor before (or during) transport.
For severe disease, assume the factor level is 0%.
Do not waste factor (administer excess rather than discarding).
Use an indwelling central catheter to administer factor if present. If not, the most experienced individuals should perform venipunctures and place an intravenous line if needed. Traumatic venipunctures can cause painful hematomas that limit intravenous access.
The treatment of choice in hemophilia A patients is the patient's own factor VIII product or recombinant human factor VIII. If neither is available, give plasma-derived factor VIII.
For severe bleeding in patients without an inhibitor, give factor VIII at 40 to 50 units/kg as soon as possible to produce a factor VIII level of 80 to 100%.
For less-severe joint or muscle bleeding, a target factor VIII level of 40 to 50% may be used, by giving factor VIII at a dose of 20 to 25 units/kg.
For severe bleeding in patients with an inhibitor, a bypassing product may be indicated (rFVIIa or FEIBA).
For individuals with mild hemophilia A (baseline factor VIII 5 to 50%) who have a documented response to DDAVP and non-life-threatening (or non-limb-threatening) bleeding, DDAVP may be used.
For potentially serious or life-threatening bleeding, give factor before imaging or other evaluations.
Initial examination findings may be subtle or absent; treat based on the medical history.
If a diagnostic procedure is required (lumbar puncture, arterial blood gas, arthrocentesis), give factor to raise the level to 100% before performing the procedure.
If the patient requires transfer to another facility, give factor before (or during) transport.
For severe disease, assume the factor level is 0%.
Do not waste factor (administer excess rather than discarding).
Use an indwelling central catheter to administer factor if present. If not, the most experienced individuals should perform venipunctures and place an intravenous line if needed. Traumatic venipunctures can cause painful hematomas that limit intravenous access.
The treatment of choice in hemophilia A patients is the patient's own factor VIII product or recombinant human factor VIII. If neither is available, give plasma-derived factor VIII.
For severe bleeding in patients without an inhibitor, give factor VIII at 40 to 50 units/kg as soon as possible to produce a factor VIII level of 80 to 100%.
For less-severe joint or muscle bleeding, a target factor VIII level of 40 to 50% may be used, by giving factor VIII at a dose of 20 to 25 units/kg.
For severe bleeding in patients with an inhibitor, a bypassing product may be indicated (rFVIIa or FEIBA).
For individuals with mild hemophilia A (baseline factor VIII 5 to 50%) who have a documented response to DDAVP and non-life-threatening (or non-limb-threatening) bleeding, DDAVP may be used.
👍3❤1🤣1
Internal Medicine Cases
What would be the coagulative panel of the patient?
The patient coagulation panel is shown in the picture.
After receiving factor, brain CT scan was done which showed bleeding in the right ocipitotemporal area.
Neurosurgery consult was ordered.
After receiving factor, brain CT scan was done which showed bleeding in the right ocipitotemporal area.
Neurosurgery consult was ordered.
👍4
Internal Medicine Cases
A few moments later the monitor showed blood pressure rise to 200/120. The patient became dyspneic. The ECG is shown in the picture.
What is the best next action beside neurosurgeric operation plan for the current situation of the patient?
Anonymous Quiz
22%
Administer Labetalol
11%
Administer TNG
14%
Administer atropin
10%
Pace maker insertion
34%
Administer IV mannitol
5%
Checking troponin
5%
Cardiologist consult for angiography
👍5
Case number 29
A 50 y/o man came to the emergency ward with the chief complaint of low back pain. The pain started 2 months ago and suddenly exacerbated 3 days prior to his admission.
He described it very severe and can not even change his position due to severe pain.
He mentioned significant weight loss and episodic fever and chills.
His vital signs at the beginning
BP 130/80
PR 100/min
SPO2 90%
T 37.3
A 50 y/o man came to the emergency ward with the chief complaint of low back pain. The pain started 2 months ago and suddenly exacerbated 3 days prior to his admission.
He described it very severe and can not even change his position due to severe pain.
He mentioned significant weight loss and episodic fever and chills.
His vital signs at the beginning
BP 130/80
PR 100/min
SPO2 90%
T 37.3
What is your next step?
Anonymous Quiz
30%
Emergent Thoracolumbosacral CT scan
39%
Emergent Lumbosacral MRI + GAD
7%
NSAID administration
24%
Extensive lower back physical examination
On physical examination, there was significant point tenderness in L1-L3 vertebrae. No other skin or muscle abnormalities were detected. Lower extremities forces were intact without any weakness.
Suddenly one of the students noticed an abnormal bulging near the manubrium of the sternum which was warm and had erythema and also tender.
Suddenly one of the students noticed an abnormal bulging near the manubrium of the sternum which was warm and had erythema and also tender.
❤2
What is the most important question you ask?
Anonymous Quiz
27%
History of IV drug abuse
4%
History of unsafe sex
6%
History of cardiac device
4%
History of dysuria and frequency
32%
History of close contact to a patient with tuberculosis
7%
History of working as a Shepherd
20%
History of previous malignancy
What is the most probable etiology of these problems?
Anonymous Quiz
11%
Monoclonal heavy chain immunoglobulins
7%
Ridstenberg cells
60%
Methicillin Resistant Staphylococcus Aureus
5%
Trauma and multiple site fracture
1%
Escherichia coli
16%
Auto antibodies + spondyloarthropathy
Case follow up
Coincident with our presumption, Methicillin Resistant Staphylococcus Aureus grew up in sternoclavicular synovial fluid. Vancomycin was started as soon as possible.
Regarding the patient's dyspnea and hypoxia, chest CT scan was done which showed bilateral nodules and round masses and bilateral multilobar pleural based lesions.
Urine analysis:
SG 1025
WBC 0-1
RBC many
Bacteria few
Ep cell 1-2
Protein 3+
Nitrite negative
Coincident with our presumption, Methicillin Resistant Staphylococcus Aureus grew up in sternoclavicular synovial fluid. Vancomycin was started as soon as possible.
Regarding the patient's dyspnea and hypoxia, chest CT scan was done which showed bilateral nodules and round masses and bilateral multilobar pleural based lesions.
Urine analysis:
SG 1025
WBC 0-1
RBC many
Bacteria few
Ep cell 1-2
Protein 3+
Nitrite negative
❤3
What is the most probable etiology of lung lesions?
Anonymous Quiz
15%
Malignancy metastasis
31%
Pneumonia
6%
Pulmonary thromboembolism
42%
Septic emboli
5%
COPD exacerbation
What is the most probable etiology of the urinary abnormalities?
Anonymous Quiz
21%
Urinary tract infection
22%
Post streptococcal glumeronephritis
15%
Post infection glumeronephritis
6%
Diabetic nephropathy
29%
Subacute bacterial endocarditis associated glumeronephritis
8%
HIV nephropathy
What is your next step?
Anonymous Quiz
13%
Kidney biopsy
4%
Starting Captopril
2%
Starting Atorvastatin
14%
Doppler sonography of renal veins
66%
Trans thoracic echocardiography